Microsoft word - app_note_10_estrogen_assay_26_04_07_flt_fuer_homepage.doc

Innovative Optische Messtechnik GmbH
Rudower Chaussee 29
12489 Berlin
www.iom-berlin.de

Application Note 10
Measurement of
Estrogen Receptor-
β Assay
with LF502NanoScan FLT

measurement date: 26/04/2007

Aim of the experiment:

evaluation of an Estrogen Receptor-β Competitor Assay
(Invitrogen Corporation, Carlsbad, CA, USA; Part # P2615, P2700)
for fluorescence lifetime read-out

investigation of the influence of the number of averaged laser-pulses on the z’-
comparison of two different methods of numerical curve analysis on z’-value
Sample preparation:

concentration values of stock solutions:
Fluoromon (green):

sample preparation in a black 384 well plate (Greiner Fluotrac 200): 50 µL per Well
preparation of the 2X complex with Fluoromon (2nM) and receptor (20nM) (according to Invitrogen
protocol for 70 wells x 25 µL):
in total for 2X complex: 1733,5 µL buffer + 8,75 µL Fluoromon + 7,78 µL receptor

preparation of Estradiol standard concentrations in the plate with 25 µL per well:

dilution of the Estradiol stock solution: two times 1:100 =>
stock solution with 750 nM Estradiol (for low control) Now • pipetting of 25 µL screening buffer in 3 columns of the 384 well plate • pipetting of 25 µL screening buffer in column 14 (for high control) • pipetting of 25 µL 750-nM-Estradiol stock solution in column 15 (for low control)
addition of 25 µL 1000-nM-Estradiol stock solution to A11, A12 and A13
then preparation of 1:2 dilution steps in the plate (transfer of 25 µL from row A to B,
then from B to C, .)
last step: addition of 25 µL 2X complex to all 68 wells

layout with final Estradiol concentrations:

final Estradiol concentration of low control: 375 nM
incubation: 2h

Instrument settings for Fluorescence lifetime measurements:

filter settings:

the number of laser pulses per well to be averaged over was varied between 1 and 128 in order to investigate the influence on the z’ value Results:

Fluorescence lifetime measurements

68 fluorescence decay curves:
complete fluorescence decay curve including rising edge averaged number of
z’-value
laser pulses per well
comparison of different methods of numerical curve analysis on standard
curves:

derived from the measurement with 32 laser pulses per well – single curve analysis (see above)
Estrogen receptor assay measured via fluorescence lifetime with LF 502NanoScan
(average of three replicates, single curve analysis)
z' = 0,89 (from 16 high and 16 low values) fluorescence lifetime [ns] 2,40
concentration Estradiol [nM]

derived from the measurement with 32 laser pulses per well – Global analysis:
complete fluorescence decay curve including rising edge Estrogen receptor assay measured via fluorescence lifetime with LF 502NanoScan
(average of three replicates, Global analysis)
z' = 0,89 (from 16 high and 16 low values) mean fluorescence lifetime [ns]
concentration Estradiol [nM]
Conclusion:

- The Estrogen receptor-β assay is easily readable using fluorescence lifetime
- High z’ values are achieved with only 4 to 8 laser pulses per well.
- Single curve analysis (fast method) with single-exponential model is sufficient
for high statistical data quality.
- Global analysis with a double-exponential model (physically correct, slower
method) yields the same level of z’-values and slightly better standard curves.

Source: http://www.iom-berlin.de/pdfs/App_Note_10_Estrogen_Assay.pdf

chrisdimattina.net

RAPID COMMUNICATION GABA and Trk Receptor Signaling Mediates Long-LastingVIBHAKAR C. KOTAK,1 CHRISTOPHER DIMATTINA,1 AND DAN H. SANES1,21 Center for Neural Science and 2 Department of Biology, New York University, New York, New York 10003 Received 27 November 2000; accepted in final form 23 March 2001 Kotak, Vibhakar C., Christopher DiMattina, and Dan H. Sanes. Stimulation of MNTB affer

splf.fr

■ Chimiothérapie et dans les cancers ORL, alors que le libelléLimousin, ont été mises en œuvre en 2002 des cancers pulmonaires : de l’AMM le réserve aux cancers du sein etpour notamment améliorer les conditions de un état des lieux préoccupant préparation des chimiothérapies et mieuxinformer les établissements des démarches Dans une dépêche, l’agence APM-Reuters,

Copyright © 2018 Medical Abstracts